Theravance Biopharma
TBPH
TBPH
125 hedge funds and large institutions have $1.11B invested in Theravance Biopharma in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 42 increasing their positions, 28 reducing their positions, and 13 closing their positions.
Holders
125
Holders Change
+20
Holders Change %
+19.05%
% of All Funds
2.57%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
35
Increased
42
Reduced
28
Closed
13
Calls
$39K
Puts
$1.03M
Net Calls
-$987K
Net Calls Change
+$348K
Top Buyers
1 |
O
1
OrbiMed
New York
|
$53.6M |
2 |
2
Jane Street
New York
|
$25.6M |
3 |
PCM
3
Peregrine Capital Management
Minneapolis,
Minnesota
|
$9.49M |
4 |
4
Wellington Management Group
Boston,
Massachusetts
|
$94.1M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$98.6M |